Skip to main content

Clonazepam (International)

In the US, Clonazepam (clonazepam systemic) is a member of the following drug classes: benzodiazepine anticonvulsants, benzodiazepines and is used to treat Anxiety, Benzodiazepine Withdrawal, Bipolar Disorder, Borderline Personality Disorder, Burning Mouth Syndrome, Chronic Myofascial Pain, Cluster-Tic Syndrome, Epilepsy, Hyperekplexia, Insomnia, Lennox-Gastaut Syndrome, Meniere's Disease, Migraine Prevention, Night Terrors, Obsessive Compulsive Disorder, Panic Disorder, Periodic Limb Movement Disorder, Primary Orthostatic Tremor, Restless Legs Syndrome, Seizure Prevention, Seizures, Sleep Paralysis and Temporomandibular Joint Disorder.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AE01

CAS registry number (Chemical Abstracts Service)

0001622-61-3

Chemical Formula

C15-H10-Cl-N3-O3

Molecular Weight

316

Therapeutic Categories

Antiepileptic agent

Benzodiazepine derivative

Chemical Name

2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs